Another study showed that the expression of ACE2 would be increased in the inflamed colon and rectum of IBD patients compared to the non-inflamed one of patients with disease in remission and in controls, while at the ileal level the expression would be reduced [64]. Here, ACE2 is linked to inflammatory bowel disease.